Phase 2 PTSD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For all participants:
- You are willing and able to give your consent to take part in the study
- You are willing to follow all study procedures and are available for the full length of the study
- You are between 21 and 65 years old
- You are able to read and communicate in English
- You use cannabis (marijuana/THC) on fewer than 3 days per week
For people with PTSD:
- You have been diagnosed with PTSD according to current medical guidelines, with symptoms lasting at least 1 month
- Your PTSD symptoms score at or above a certain level on a standard assessment scale at the time you join the study (confirm with trial site)
- You have been on a stable mental health medication or therapy program for at least 4 weeks before joining
Who may not be able to join:
For all participants:
- You are currently using any prescribed or over-the-counter CBD products (including the medication Epidiolex®)
- You have had recent serious thoughts of suicide or made a suicide attempt within the past 6 months, as measured by a standard assessment tool
- You have a thinking or memory problem that the study doctor believes would affect your ability to complete the study
- You have had a moderate or serious problem with drug or alcohol use in the past 6 months (tobacco/nicotine use is allowed)
- You have been using cannabis more than 3 days per week in the 4 weeks before joining
- Your urine drug test comes back positive for any illegal substances other than cannabis
- You are pregnant (confirmed by a blood test) or currently breastfeeding
- You have a serious medical condition or are taking certain medications that the study doctor believes could make it unsafe for you to participate (confirm with trial site)
- You have taken part in another research drug study or treatment trial within the past 3 months
- You have a history of psychosis, active bipolar disorder, or borderline personality disorder diagnosed by a mental health professional
- You have a history of an open head injury (a brain injury where the skull was broken)
- You experienced a traumatic event within the past 30 days
- You are currently on active military duty within the past 30 days
- You have been admitted to a psychiatric hospital within the past 6 months
- You have had a seizure in the past 6 months
- You are currently taking HIV antiviral medications (note: PrEP, a medication to prevent HIV, is allowed)
For people without PTSD (control participants):
- You have a previous diagnosis of PTSD
- You are pregnant (by self-report) or currently breastfeeding
For participants who agree to have an MRI brain scan:
- You have claustrophobia (fear of enclosed spaces), are pregnant, or have a condition the study doctor believes would make an MRI unsafe for you
- You have any metal objects in or on your body, such as a pacemaker, metal implants, certain dental devices, cochlear implants, non-removable piercings, or metal fragments in your body
- You have another medical condition the study doctor believes would interfere with the MRI scan (confirm with trial site)
Additional exclusions for people with PTSD:
- Your only traumatic experience happened before the age of 18 and you have had no other traumas that could be connected to your PTSD
- You have had an allergic reaction or serious side effects related to cannabis, CBD, or THC in the past
- You are currently in a situation that is actively causing your PTSD
- Your liver function blood test results are significantly above the normal range at the time of screening
- If you are able to become pregnant, you are not willing to use at least one form of birth control throughout the study (acceptable methods include condoms, diaphragm, abstinence, or hormonal/implanted contraception such as the pill, injection, or IUD)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Matthew Rizzo, MD, University of Nebraska
Phone: 402-552-6239
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Post-traumatic Stress Disorder Symptom Rating
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.